ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,099.96
      1.02%
      US Tech 100
      17,244.00
      1.57%
      Dow Jones
      38,239.66
      0.40%
      Brent Oil
      88.165
      0.00%
      Bitcoin
      63,544.85
      0.21%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Mainz BioMed NV (MYNZ)

      7. Mainz BioMed NV (MYNZ) News

      MYNZ

      Mainz BioMed NV (MYNZ)

      Mainz BioMed NV
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:MYNZ
      DateTimeSourceHeadlineSymbolCompany
      04/25/20249:29AMGlobeNewswire Inc.Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer DiagnosticNASDAQ:MYNZMainz BioMed NV
      04/09/20248:01AMGlobeNewswire Inc.Mainz Biomed Reports Full Year 2023 Financial ResultsNASDAQ:MYNZMainz BioMed NV
      03/19/20248:01AMGlobeNewswire Inc.Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer TreatmentNASDAQ:MYNZMainz BioMed NV
      03/18/20248:01AMGlobeNewswire Inc.Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic OptionsNASDAQ:MYNZMainz BioMed NV
      03/12/20248:01AMGlobeNewswire Inc.Mainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening InnovationsNASDAQ:MYNZMainz BioMed NV
      03/05/20248:01AMGlobeNewswire Inc.Mainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer DiagnosticNASDAQ:MYNZMainz BioMed NV
      02/27/20248:01AMGlobeNewswire Inc.Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical CommunityNASDAQ:MYNZMainz BioMed NV
      02/22/20248:01AMGlobeNewswire Inc.Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®NASDAQ:MYNZMainz BioMed NV
      02/21/20248:01AMGlobeNewswire Inc.Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in ItalyNASDAQ:MYNZMainz BioMed NV
      02/06/20248:01AMGlobeNewswire Inc.Mainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in GermanyNASDAQ:MYNZMainz BioMed NV
      01/11/20248:01AMGlobeNewswire Inc.Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology SymposiumNASDAQ:MYNZMainz BioMed NV
      01/09/20248:01AMGlobeNewswire Inc.Mainz Biomed Provides Year-End Corporate Review 2023NASDAQ:MYNZMainz BioMed NV
      12/19/20238:01AMGlobeNewswire Inc.Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for EmployeesNASDAQ:MYNZMainz BioMed NV
      12/12/20238:01AMGlobeNewswire Inc.Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in PolandNASDAQ:MYNZMainz BioMed NV
      12/05/20239:01AMGlobeNewswire Inc.Mainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA BiomarkersNASDAQ:MYNZMainz BioMed NV
      11/29/20238:01AMGlobeNewswire Inc.Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via WebcastNASDAQ:MYNZMainz BioMed NV
      11/20/20238:01AMGlobeNewswire Inc.Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:MYNZMainz BioMed NV
      11/16/20238:01AMGlobeNewswire Inc.Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:MYNZMainz BioMed NV
      11/15/20239:01AMGlobeNewswire Inc.Mainz Biomed Announces Closing of $5.0 million Registered Direct OfferingNASDAQ:MYNZMainz BioMed NV
      11/13/20239:00AMGlobeNewswire Inc.Mainz Biomed Announces Pricing of $5.0 million Registered Direct OfferingNASDAQ:MYNZMainz BioMed NV
      11/09/20238:01AMGlobeNewswire Inc.Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening TestNASDAQ:MYNZMainz BioMed NV
      11/07/20238:01AMGlobeNewswire Inc.Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICANASDAQ:MYNZMainz BioMed NV
      10/31/20238:01AMGlobeNewswire Inc.Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-KipperNASDAQ:MYNZMainz BioMed NV
      10/26/20238:01AMGlobeNewswire Inc.Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial OperationsNASDAQ:MYNZMainz BioMed NV
      10/18/20238:01AMGlobeNewswire Inc.Mainz Biomed Presents Groundbreaking Results of ColoFuture StudyNASDAQ:MYNZMainz BioMed NV
      10/11/20238:01AMGlobeNewswire Inc.Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, DenmarkNASDAQ:MYNZMainz BioMed NV
      10/05/20238:01AMGlobeNewswire Inc.Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit NASDAQ:MYNZMainz BioMed NV
      10/04/20238:01AMGlobeNewswire Inc.Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in RomaniaNASDAQ:MYNZMainz BioMed NV
      09/27/20238:01AMGlobeNewswire Inc.Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on GastroenterologyNASDAQ:MYNZMainz BioMed NV
      09/20/20233:01AMGlobeNewswire Inc.Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference NASDAQ:MYNZMainz BioMed NV
       Showing the most relevant articles for your search:NASDAQ:MYNZ